National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)

Background
The National Institute on Drug Abuse (NIDA) Epidemiology Research Program promotes work that informs and facilitates real-world responses designed to reduce the burden of substance use, misuse, and/or addiction on the Nation’s health. The landscape of drug use and misuse in the United States has become increasingly complex in recent years. The U.S. continues to grapple with the consequences of the opioid crisis, which was identified as a nationwide public health emergency in 2017.

Grant Details
The purpose of this notice of funding opportunity (NOFO) is to fund a single Coordinating Center to enhance the NIDA Epidemiology Research Program’s research efforts to identify and address emerging drug threats in a timely fashion. Working collaboratively with NIDA, the Center will use multiple sources of data to identify and track key indicators related to drug use, including the availability and use of new psychoactive substances or new combinations of substances and other consequences of drug use, with a particular emphasis on 'leading' and real-time indicators that can facilitate the early identification of emerging drug threats, providing opportunities for intervention.

Eligibility Requirements
All organizations administering an eligible parent award may apply for a supplement under this NOFO. Eligible organizations include higher education institutions, nonprofits other than institutions of higher education, for-profit organizations, local governments, state governments, county governments, city or township governments, special district governments, Indian/Native American tribal governments (federally recognized), Indian/Native American tribal governments (other than federally recognized), federal government agencies or eligible agencies of the federal government.

Period of Performance
The maximum project period is 5 years.

Grant Value
NIDA intends to commit $1,000,000 in FY 2025 to fund one award.